Skip to main content
Contact Us
Subscribe
e-Edition
Sign Up
Log In
Dashboard
Logout
My Account
Dashboard
Profile
Saved items
Logout
Site search
Search
Toggle navigation
Contact Us
Subscribe
Promote Your Event
e-Edition
Privacy Policy
Terms of Service
Local Weather
Home Delivery
Submission Forms
News
Local News
The Leader
Heartland News
Sports
Entertainment
Local Events
Multimedia
Photo Galleries
Videos
Obituaries
Classifieds
Real Estate
Property for Rent
Cars & Vehicles
Jobs
Items for Sale
Pets
Auctions, Estate & Garage Sales
Services
Community
Personals
Place an ad
Legals
Best of 2022
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Eli Lilly
(NY:
LLY
)
538.29
+1.16 (+0.22%)
Official Closing Price
Updated: 7:00 PM EDT, Oct 2, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Eli Lilly
< Previous
1
2
3
4
5
6
7
8
9
...
48
49
Next >
Immunomics Stocks: 3 Ways to Play This Massive AI-Biotech Megatrend
September 22, 2023
Ginkgo Bioworks, Recursion Pharmaceutical, and Eli Lilly are cashing in on the AI-Biotech trend of tomorrow using the big data of today.
Via
InvestorPlace
'Stocks In Monopolistic Bull Market': Wall Street Analyst Contemplates A Bright Future For Next Phase
September 22, 2023
The analyst illustrated how the dominant force in stock market returns for 2023 has been the "Magnificent 7."
Via
Benzinga
Are Wall Street Analysts Wrong About Eli Lilly Stock?
September 22, 2023
Based on analysts' projections, you might think the pharmaceutical giant isn't worth investing in right now.
Via
The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
September 21, 2023
Via
Benzinga
Peering Into Eli Lilly's Recent Short Interest
September 20, 2023
Via
Benzinga
Eli Lilly Unusual Options Activity
September 19, 2023
Via
Benzinga
1 Growth Stock That Could Turn $1,000 Into $2,500 by 2030
September 16, 2023
The stock has delivered market-beating returns in the past. It can do it again.
Via
The Motley Fool
The 7 Most Hated Stocks by Institutional Traders
September 20, 2023
Discover the surprising stocks institutional traders are selling, and find out what their moves could mean for your portfolio's future.
Via
InvestorPlace
Elon Musk-Backed Neuralink Starts Participant Enrollment For Paralysis, Eli Lilly Cracks Down on Counterfeit Weight Loss Drugs, Meta Looks to Capitalize on India's In-App Payment Surge: Today's Top Stories
September 20, 2023
Benzinga
Via
Benzinga
Eli Lilly Cracks Down on Counterfeit Mounjaro Wight Loss and Diabetes Drugs, Sues Lawsuit Against Clinics
September 20, 2023
Eli Lilly And Co (NYSE: LLY) has taken
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
3 Healthcare Stocks That Turned $100,000 Into $1 Million in 10 Years
September 20, 2023
Are these highly successful stocks still good buys today?
Via
The Motley Fool
Here's How Much You Would Have Made Owning Eli Lilly Stock In The Last 15 Years
September 15, 2023
Via
Benzinga
2 Stocks That Moved the Market in August
September 14, 2023
These two stocks illustrate the most important trends in the market right now.
Via
The Motley Fool
Check Out What Whales Are Doing With LLY
September 12, 2023
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
September 18, 2023
Via
Benzinga
10 Health Care Stocks Whale Activity In Today's Session
September 15, 2023
Via
Benzinga
3 (Bad) Reasons to Avoid or Sell Novo Nordisk Stock
September 15, 2023
The rhetoric surrounding popular businesses isn't always good advice.
Via
The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
September 14, 2023
Via
Benzinga
Madrigal Pharmaceuticals Surges As Its NASH Treatment Toes The Long-Awaited Finish Line
September 13, 2023
The company is toeing the finish line with a NASH treatment, an area of medicine marked by failures.
Via
Investor's Business Daily
The Gravity-Defying Lilly
September 10, 2023
Honestly, I’ve never seen anything like Eli Lilly before. All it does is go up, and up, and then up some more. It’s like how people are famous for being famous. This stock goes up because it goes up.
Via
Talk Markets
Should You Still Buy the S&P 500's Best-Performing August Stocks?
September 12, 2023
These high-flying S&P 500 stocks could have more room to run.
Via
The Motley Fool
Topics
Stocks
Exposures
US Equities
Wall Street Has Found Its Next High-Flying Stock-Split Stock. Here's Why I'm Not Buying the Hype.
September 12, 2023
Nvidia, Amazon, DexCom, Shopify, Alphabet, Tesla, Palo Alto Networks, and Monster Beverage have all split their shares since July 2021. Next week, another industry leader will join this exclusive...
Via
The Motley Fool
Pound for Pound: 3 Buzzworthy Drug Stocks Worth Their Weight in Gold
September 11, 2023
Investors looking for exposure to a booming business should hitch their wagons to one of these leading pharmaceutical companies.
Via
InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
September 11, 2023
Via
Benzinga
Investors May Not Have Seen the Best From Eli Lilly Stock Yet. Here's Why.
September 10, 2023
Mounjaro has been on the market for roughly one year and is already generating billions in sales for Eli Lilly. But with that said, its best days could be ahead.
Via
The Motley Fool
3 Unstoppable Growth Stocks to Buy Right Now
September 09, 2023
These healthcare stocks show no signs of slowing down.
Via
The Motley Fool
Only 2 Mega-Cap Monster Stocks Have Risen in Each of the Last 5 Years: Are They Buys Now?
September 09, 2023
There's no guarantee their winning streaks will continue. But don't be surprised if they do.
Via
The Motley Fool
10 Health Care Stocks With Whale Alerts In Today's Session
September 08, 2023
Via
Benzinga
Did Elon Musk Admit 90% Decline In Twitter's Value Since Acquisition?, Apple's Zero-Click Vulnerabilities Uncovered By Internet Watchdog Group, Gas Prices Jump As Strikes Start At Major Chevron Australia LNG Projects: Today's Top Stories
September 08, 2023
Benzinga
Via
Benzinga
UK Authority Recommends Eli Lilly's Famed Diabetes Drug Mounjaro As New Treatment Option For Type 2 Diabetes
September 08, 2023
UK's National Institute for Health and Care Excellence (NICE) has endorsed Eli Lilly And Co's (NYSE: LLY) diabetes medication, Mounjaro (tirzepatide), indicating it as a viable option for patients...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
48
49
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.